MetLife Investment Management’s Oscar Health OSCR Stock Holding History

MetLife Investment Management’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.27M	Buy	110,668 +613	+0.6%	+$8.64K	0.01%	1289
2025 Q4	$1.58M	Sell	110,055 -3,296	-3%	-$57K	0.01%	1196
2025 Q3	$2.15M	Buy	113,351 +3,785	+3%	+$62.4K	0.01%	1054
2025 Q2	$2.35M	Sell	109,566 -9,825	-8%	-$146K	0.01%	929
2025 Q1	$1.57M	Buy	119,391 +358	+0.3%	+$5.32K	0.01%	1151
2024 Q4	$1.6M	Buy	119,033 +6,553	+6%	+$106K	0.01%	1176
2024 Q3	$2.39M	Hold	112,480	–	–	0.01%	925
2024 Q2	$1.78M	Buy	112,480 +30,264	+37%	+$556K	0.01%	1030
2024 Q1	$1.22M	Hold	82,216	–	–	0.01%	1188
2023 Q4	$752K	Hold	82,216	–	–	0.01%	1454
2023 Q3	$458K	Hold	82,216	–	–	﹤0.01%	1692
2023 Q2	$663K	Buy	82,216 +16,471	+25%	+$121K	﹤0.01%	1507
2023 Q1	$430K	Buy	65,745 +17,310	+36%	+$70.7K	﹤0.01%	1734
2022 Q4	$119K	Sell	48,435 -16,948	-26%	-$53K	﹤0.01%	2510
2022 Q3	$326K	Hold	65,383	–	–	﹤0.01%	1940
2022 Q2	$278K	Buy	+65,383	New	+$416K	﹤0.01%	2071

Other funds holding OSCR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return

BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MetLife Investment Management's OSCR Position: Q1 2026 in Review

MetLife Investment Management increased its Oscar Health (OSCR) stake by 0.56% in Q1 2026, buying an estimated $8.64K and bringing the position to 110,668 shares worth $1.27M. The position accounts for 0.01% of the portfolio, ranked #1289.

MetLife Investment Management first reported a position in OSCR in Q2 2022 and has held it in 16 quarters since. The position peaked at $2.39M in Q3 2024. 330 funds tracked by Wall St. Rank hold OSCR as of Q1 2026.

MetLife Investment Management held 110,668 shares of Oscar Health worth $1.27M as of Q1 2026.
MetLife Investment Management bought 613 Oscar Health shares in Q1 2026, an estimated $8.64K.
Oscar Health made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1289 holding.
MetLife Investment Management first reported a position in Oscar Health in Q2 2022 and has held it in 16 quarters since.
MetLife Investment Management's Oscar Health position peaked at $2.39M in Q3 2024.
330 funds tracked by Wall St. Rank held Oscar Health as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.